HomeMarketsSharesDiageo Adr Rep 4

Trade Diageo Adr Rep 4 - DEO CFD

Market is not available at the momentMarket information is presented
as of 2026-10-09T19:46:41+00:00
Trading Conditions
Type
This financial market is available for CFD trading.
Learn more about:CFDs
CFD
Spread0.25
Long position overnight funding adjustment
Long position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.022179 %
(-$4.44)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.02218%
Short position overnight funding adjustment
Short position overnight funding adjustment

Margin. Your investment
$1,000.00
Overnight funding adjustment
Charges from full value of position
-0.000043 %
(-$0.01)

Trade size with leverage ~ $20,000.00

Money from leverage ~ $$19,000.00


-0.00004%
Overnight funding adjustment time21:00 (UTC)
CurrencyUSD
Min traded quantity0.1
Margin5.00%
Stock exchangeUnited States of America
Commission on trade10%
Guaranteed stop premium
A guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.
1%

1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information

Key Stats
Prev. Close86.88
Open86.62
1-Year Change-9.48%
Day's Range86.27 - 87

Trade Diageo Adr Rep 4 - DEO

​​Diageo is a global producer of well-known alcoholic beverages. Its collection of over 200 brands includes Baileys, Smirnoff and Johnnie Walker. The company has a presence in 180 countries.

A member of the FTSE100, the company is listed on the London Stock Exchange (LSE) under the ticker DGE. It has a secondary listing on the New York Stock Exchange (NYSE) under the symbol DEO.

Diageo was founded in 1997 through the merger of Grand Metropolitan and Guinness. In 2000, it consolidated its operations to focus on premium alcoholic beverages.

Years of acquisitions followed. In 2001, the London-based company acquired some of the Seagram wine and spirits business. Ten years later, the company purchased Turkey’s leading spirits producer, Mey Içki, for £1.3bn.

In 2012, Diageo announced a £1bn investment in Scottish whisky production. That same year, it acquired the Meta Abo Brewery in Ethiopia, Shui Jing Fang in China, Hanoi Vodka in Vietnam and Ypióca in Brazil. Two years later, it acquired Peligroso Tequila from the California-based Peligroso Spirits Company.

To further concentrate  on its liquor business, in 2015 the company sold the world-famous Gleneagles Hotel in Scotland to Ennismore, a private investment company.

On 24 January 2022, Diageo announced that it had agreed to sell the Meta Abo Brewery to BGI, part of Castel Group.

From 2021 to early 2022, the company made three acquisitions. In March 2021, Diageo acquired Far West Spirits, the owner of the Lone River Ranch Water (Lone River) brand. The following month, it bought US brand Loyal 9 Cocktails from the Sons of Liberty Spirits Company.

On 28 January 2022, the company completed the acquisition of Casa UM, owner of premium artisanal mezcal brand, Mezcal Unión.

Diageo has a market cap of $115.39bn as of February 2022, making it the world’s 123th most valuable company, according to Companies Market Cap.

Latest shares articles

A GameStop store in Portland, Oregon
GameStop stock forecast: debt exchange, Q2 profit
GameStop is a US video-game retailer. In Q2 fiscal 2026, net sales fell to $790.2m, while operating income rose to $160.2m. Explore third-party GME price targets and technical analysis. Past performance is not a reliable indicator of future results.
14:06, 7 October 2026
Freenet stock forecast
Freenet stock forecast: revenue rises, EBITDA falls
Freenet reported first-half 2026 revenue of €1,512.9 million, up 24.7% year on year, while adjusted EBITDA fell 5.9% to €242.2 million and 2026 guidance was maintained. Explore third-party FNTN price targets and technicals. Past performance is not a reliable indicator of future results.
12:41, 7 October 2026
Hims & Hers Health stock forecast
Hims & Hers Health stock forecast: FDA GLP-1 warning
Hims & Hers Health is a US telehealth company. In August 2026, the FDA issued a warning concerning unapproved compounded GLP-1 weight-loss drugs. Explore third-party HIMS price targets and technical analysis. Past performance is not a reliable indicator of future results.
12:18, 7 October 2026
Arm Holdings stock forecast
Arm Holdings stock forecast: Haas flags AI demand
Arm Holdings is a UK-based semiconductor company. Chief executive Rene Haas said AI and data-centre demand showed no signs of slowing. Explore third-party ARM price targets and technical analysis. Past performance is not a reliable indicator of future results.
09:43, 6 October 2026

User feedback and ratings

Showing our 4 & 5 star reviews. The specific details of the user have been intentionally anonymised to safeguard their privacy pursuant to GDPR requirements.

Ready to join a leading broker?

1. Create your account2. Make your first deposit3. Start when you’re ready